(Q43953966)

28 November 2017

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis? (English)

1 reference

28 November 2017

Maki Arai

1

1 reference

PubMed ID

11943320

28 November 2017

Donald D Earl

series ordinal

2

1 reference

PubMed ID

11943320

28 November 2017

Janet K Yamamoto

series ordinal

3

1 reference

28 November 2017

1 March 2002

1 reference

Veterinary Immunology and Immunopathology

28 November 2017

1 reference

28 November 2017

85

1 reference

28 November 2017

3-4

1 reference

28 November 2017

189-204

1 reference

The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Clinical and pathological findings in feline immunodeficiency virus experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

HIV-specific cellular and humoral immune responses in primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

In vivo lymphocyte tropism of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Long-term treatment of diseased, FIV-seropositive field cats with azidothymidine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Toxicity associated with high dosage 9-[(2R,5R-2,5-dihydro-5-phosphonomethoxy)-2-furanyl]adenine therapy and attempts to abort early FIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Tenth anniversary perspectives on AIDS. FIV as a model for AIDS vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Domestic cat model for predicting human nucleoside analogue pharmacokinetics in blood and seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5'-triphosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Feline immunodeficiency virus infection: plasma, but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Superinfection of cats with feline immunodeficiency virus subtypes A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Short-term stability of HIV provirus levels in the peripheral blood of HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Evaluation of 9-(2-phosphonylmethoxyethyl) adenine therapy for feline immunodeficiency virus using a quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Human immunodeficiency virus type-1 can be detected in monocytes by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Characterization of the RNA dependent DNA polymerase of a new human T lymphotropic retrovirus (lymphadenopathy associated virus)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Pathogenesis of acute infection in rhesus macaques with a lymphocyte-tropic strain of simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Effect of 3'azido-2',3'-deoxythymidine (AZT) on experimental feline immunodeficiency virus infection in domestic cats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Feline immunodeficiency virus infection. Clinicopathologic findings in 90 naturally occurring cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Severe anemia as a newly recognized side-effect caused by lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Experimental vaccine protection against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

Feline bone marrow transplantation: its use in FIV-infected cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900426-3

7 January 2021

10.1016/S0165-2427(01)00426-3

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11943320